STOCKWATCH
·
Surgical & Medical Instruments & Apparatus
Quarterly ResultMay 13, 2026, 04:13 PM

Shoulder Innovations Q1 Revenue +65% to $16.7M; Raises FY26 Outlook

AI Summary

Shoulder Innovations, Inc. reported strong financial results for the first quarter ended March 31, 2026, with net revenue increasing 65% year-over-year to $16.7 million. The company also achieved a higher gross margin of 77.7% and saw a 51% increase in implant system sales. Building on this performance, Shoulder Innovations raised its full-year 2026 net revenue guidance to a range of $65 million to $68 million, reflecting increased confidence in its business trajectory.

Key Highlights

  • Net revenue increased 65% to $16.7 million in Q1 2026 from $10.1 million in Q1 2025.
  • Gross margin improved to 77.7% in Q1 2026 from 76.9% in Q1 2025.
  • Sold 2,184 total implant systems in Q1 2026, a 51% increase year-over-year.
  • Average selling price of implant systems increased 9% to $7,650 in Q1 2026.
  • Raised full year 2026 net revenue guidance to $65 million to $68 million (37%-44% growth).
  • Prior full year 2026 net revenue guidance was $62 million to $65 million (31%-37% growth).
  • Operating loss was $9.0 million in Q1 2026, compared to $4.3 million in Q1 2025.
  • Net loss was $8.4 million in Q1 2026, compared to $4.7 million in Q1 2025.
SI
Surgical & Medical Instruments & Apparatus
SHOULDER INNOVATIONS, INC.

Price Impact